CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines

CountryFocus: Healthcare, Regulatory and 

Reimbursement Landscape Philippines 

Released On 27 th June 2014 

The industry analysis specialist, has 

released its latest report, CountryFocus: 

Healthcare, Regulatory and 

Reimbursement Landscape Philippines. 

The report is an essential source of 

information and analysis regarding the 

healthcare, regulatory and 

reimbursement landscape in the 

Philippines. It identifies key trends in 

the healthcare market and provides 

insights into the demographic, 

regulatory, reimbursement landscape 

and healthcare infrastructure in the 

country. Most importantly, the report provides valuable insights into the trends and segmentation 

of the pharmaceutical and medical device markets. This resource has been produced using data 

and information from proprietary databases, secondary research, and in-house analysis by 

GlobalDatas team of industry experts. 

Buy this report OR Know more : http://www.jsbmarketresearch.com/healthcare- 

medical/r-CountryFocus-Healthcare-Regulatory-and-Reimbursement-Landscape- 

Philippines-114974 

The population of the Philippines amounted to approximately 99.2 million in 2013, making it the 

12th most populated country in the world. Population growth has primarily been due to a high 

birth rate and rising life expectancy. An increased elderly population is however a matter of 

concern for policy planners. The value of the pharmaceutical market in the country amounted to 

$4.3 billion in 2013, and it is expected to increase at a CAGR of 9.4% to reach approximately $8 

billion in 2020. 

The positive trend in the healthcare market of the Philippines can be attributed primarily 

to the following factors: 

Generic substitution in both the public and private sectors, which has been a driver for the 

manufacture of generic drugs 

JSB Market Research Pvt. Ltd. 

Email ID- contact@jsbmarketresearch.com 

Tel No- 91 2241236650 / +91 - 998 729 5242 

Published by- http:/www.jsbmarketresearch.com/

Increased expenditure on medicines by Local Government Units (LGUs) 

Government initiatives for the prevention and management of chronic diseases 

An improved and updated regulatory environment 

Scope 

This report provides information on the healthcare, regulatory, and reimbursement landscape in 

the Philippines, including the following: 

An overview of the pharmaceutical and medical device markets, comprising market size, 

segmentation, and key drivers and barriers 

Profiles and SWOT analyses for major players in the pharmaceutical market (United 

Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck) 

An insightful review of the reimbursement and regulatory landscape, including details of the 

healthcare reimbursement process, regulatory agencies, and approval processes for new drugs 

and medical devices 

Detailed analysis of the political and economic environment, covering economic indicators, 

demographics, healthcare infrastructure, and healthcare expenditure 

An overview of the opportunities for and challenges facing growth in the healthcare market 

Reasons To Buy 

This report will enhance your decision-making capability by allowing you to: 

Develop business strategies based on a sound understanding of the trends shaping and driving the 

healthcare market in the Philippines 

Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, 

pharmaceutical market segments, and the companies likely to impact the healthcare market in the 

future 

Formulate effective sales and marketing strategies by understanding the competitive landscape 

and analyzing the performance of various competitors 



Tel No- 91 2241236650 / +91 - 998 729 5242 


Organize sales and marketing efforts by identifying the market categories and segments that 

present the greatest opportunities for consolidation, investment, and strategic partnership 

Identify, understand, and capitalize upon the opportunities and challenges in the Philippines 

healthcare market 

Table of Content: 

1.1 List of Tables 

1.2 List of Figures 

2 Introduction 

2.1 GlobalData Report Guidance 

3 Overview of Pharmaceutical and Medical Device Market 

3.1 Pharmaceutical Market 

3.1.1 Market Overview 

3.1.2 Pharmaceutical Exports and Imports 

3.1.3 Supply Channels 

3.1.4 Market Segments 

3.1.5 Overview of Major Disease Areas 

3.1.6 Major Players 

3.2 Medical Device Market 

3.2.1 Market Overview 

3.3 Market Drivers and Barriers 

3.3.1 Drivers 

3.3.2 Barriers 

4 Market Access 

4.1 Reimbursement and Payer Landscape 

4.1.1 Overview of Healthcare system 

4.1.2 Reimbursement Process 

4.1.3 Overview of Insurance Providers 

4.1.4 Patient Share in Healthcare Spending 

4.1.5 Price Trends in the Healthcare Sector 

4.1.6 Pricing Policies 

4.2 Regulatory Landscape 

4.2.1 Overview of Regulatory Agencies 

4.2.2 Market Authorization Procedure for Pharmaceutical Products 

4.2.3 New Medical Device Approval Process 

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 

4.2.5 Exports and Imports 

4.2.6 Intellectual Property Rights 

4.2.7 Clinical Trial Regulations 



Tel No- 91 2241236650 / +91 - 998 729 5242 


4.2.8 Pharmaceutical Advertising Regulations 

4.2.9 Pharmacy Regulations 

4.2.10 Labeling and Packaging Regulations 

5 Country Analysis 

5.1 Political Environment 

5.1.1 Political Structure 

5.1.2 Analysis of Current Political Environment 

5.1.3 Healthcare Policy Initiatives 

5.2 Economic Landscape 

5.3 Economic Indicators 

5.3.1 Gross Domestic Product 

5.3.2 Gross National Income 

5.3.3 Inflation 

5.3.4 Currency Exchange Rate 

5.3.5 Foreign Direct Investment 

5.3.6 Foreign Exchange Reserves 

5.3.7 Trade Balance 

5.3.8 Fiscal Deficit 

5.3.9 General Government Gross Debt 

5.3.10 External Debt 

5.3.11 Major Industries 

5.4 Demographics 

5.4.1 Population 

5.4.2 Education and Literacy 

5.4.3 Employment 

5.4.4 Disease Burden 

5.5 Healthcare Infrastructure 

5.5.1 Healthcare Facilities 

5.5.2 Healthcare Parameters 

5.5.3 Environmental Health 

5.5.4 Healthcare Personnel 

5.6 Healthcare Expenditure 

5.6.1 Overview 

5.6.2 Major Components of Healthcare Spending 

5.6.3 Share of Public and Private Sector 

5.6.4 Spending in Pharmaceutical R&D 

5.7 Trade Associations 

5.7.1 Pharmaceutical and Healthcare Association of the Philippines 

5.7.2 The Philippine Pharmaceutical Manufacturers Association 

5.7.3 The Philippine Pharmacist Association 

5.7.4 The Philippine Medical Association 



Tel No- 91 2241236650 / +91 - 998 729 5242 


5.8 Trade Fairs 

6 Opportunities and Challenges 

6.1 Opportunities 

6.2 Challenges 

7 Appendix 

7.1 Abbreviations 

7.2 Bibliography 

7.3 Research Methodology 

7.3.1 Coverage 

7.3.2 Secondary Research 

7.3.3 Forecasts 

7.3.4 Expert Panel 

7.4 Disclaimer 

List of Tables 

Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 20082013 

Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 20142020 

Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 20082013 

Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for 

Multinational Companies (%), 2008 

Table 5: Pfizer, Global, Major Products, Revenue, 2013 

Table 6: Pharmaceutical Market, Global, Late-Stage Pipeline, Pfizer, 2014 

Table 7: GlaxoSmithKline, Global, Major Products, Revenue ($bn) and Annual Growth (%), 

2013 

Table 8: Pharmaceutical Market, Global, Late-Stage Pipeline, GlaxoSmithKline, 2014 

Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 

Table 10: Pharmaceutical Market, Global, Planned Filings, Novartis, 2014=2018 

Table 11: Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 

Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck, 2014 

Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2013 

Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2013 

Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 20082013 

Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector 

(%), 20082013 

Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 20082013 

Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita Forecast ($), 

20142020 

Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 

20082013 

Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 



Tel No- 91 2241236650 / +91 - 998 729 5242 


20142020 

Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 20082013 

Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 20082013 

Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 

20082013 

Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 20082013 

Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 20082013 

Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 20082013 

Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 20082013 

Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 20082013 

Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 20082012 

Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 

20082013 

Table 31: Economic Indicators, Philippines, External Debt ($bn), 20082013 

Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value 

Added ($bn), 20122013 

Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value 

Added ($bn), 20122013 

Table 34: Demographics, Philippines, Population (million), 20082013 

Table 35: Demographics, Philippines, Population Forecast (million), 20142020 

Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 

20082013 

Table 37: Demographics, Philippines, Population, Urban and Rural Population Forecast Share 

(%), 20142020 

Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 20082013 

Table 39: Demographics, Philippines, Population Distribution by Age Group Forecast (%), 

20082013 

Table 40: Demographics, Philippines, Births (per 1,000 Population), 20082013 

Table 41: Demographics, Philippines, Mortality (per 1,000 Population), 20082013 

Table 42: Demographics, Philippines, Major Causes of Mortality (000), 2010 

Table 43: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 20082013 

Table 44: Demographics, Philippines, Immunization Rate (%), 20082013 

Table 45: Demographics, Philippines, Major Causes of Male Mortality (000), 2008 

Table 46: Demographics, Philippines, Major Causes of Female Mortality (000), 2008 

Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 20082010 

Table 48: Demographics, Philippines, Gender Ratio (M:F), 20082013 

Table 49: Demographics, Philippines, Life Expectancy at Birth (Years), 20082013 

Table 50: Demographics, Philippines, Life Expectancy at Birth (Years), 20142020 

Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 20082013 

Table 52: Demographics, Philippines, Unemployment Rate (%), 20082013 



Tel No- 91 2241236650 / +91 - 998 729 5242 


Table 53: Demographics, Philippines, Major Diseases, Morbidity (000), 2010 

Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009 

Table 55: Healthcare Infrastructure, Philippines, Hospitals, 20082013 

Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 20082013 

Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 

Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 

Population), 20072009 

Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 

20082013 

Table 60: Environmental Health, Philippines, CO2 Emissions (Million Tons), 20082013 

Table 61: Environmental Health, Philippines, PM10 (gm/m), 20082013 

Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 20082013 

Table 63: Healthcare Personnel, Philippines, Registered Nurses, 20082013 

Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 20082013 

Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2011 

Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 20082013 

Table 67: Major Healthcare Trade Fairs, Philippines, 2014 

List of Figures 

Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 20082013 

Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 20142020 

Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 20082013 

Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008 

Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for 

Multinational Companies (%), 2008 

Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2013 

Figure 7: Healthcare System, Philippines, 2014 

Figure 8: Drug Selection Procedure for Philippine National Drug Formulary, Philippines, 2014 

Figure 9: Reimbursement Process, Philippines, 2014 

Figure 10: PhilHealth Milestones, Philippines, 2010 

Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2013 

Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2013 

Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 20082013 

Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector 

(%), 20082013 

Figure 15: Healthcare System, Philippines, Food and Drug Administration Structure, 2014 

Figure 16: Healthcare System, Philippines, Approval Process of New Drugs and Medical 

Devices, 2014 

Figure 17: Healthcare System, Philippines, Approval Process of Generic Drugs, 2014 

Figure 18: Healthcare System, Philippines, Bureau of Health Devices and Technology Structure, 



Tel No- 91 2241236650 / +91 - 998 729 5242 


2014 

Figure 19: Healthcare System, Philippines, Licensing Process for Manufacture of 

Pharmaceuticals and Medical Devices, 2014 

Figure 20: Healthcare System, Philippines, Patent Approval Process, 2014 

Figure 21: Healthcare System, Philippines, Trademark Approval Process, 2014 

Figure 22: Healthcare System, Philippines, Clinical Trial Approval Process, 2014 

Figure 23: Healthcare System, Philippines, Procedure for Opening a Retail Pharmacy, 2014 

Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 19992010 

Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 20082013 

Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita Forecast ($), 

20142020 

Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 

20082013 

Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth Forecast 

(%), 20142020 

Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 20082013 

Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 20082013 

Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 

20082013 

Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 20082013 

Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 20082013 

Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 20082013 

Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 20082013 

Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 20082013 

Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 20082012 

Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 

20082013 

Figure 39: Economic Indicators, Philippines, External Debt ($bn), 20082013 

Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value 

Added ($bn), 20122013 

Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value 

Added ($bn), 20122013 

Figure 42: Demographics, Philippines, Population (million), 20082013 

Figure 43: Demographics, Philippines, Population Forecast (million), 20142020 

Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 

20082013 

Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share Forecast 

(%), 20142020 

Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 20082013 

Figure 47: Demographics, Philippines, Population Distribution by Age Group Forecast (%), 

20142020 



Tel No- 91 2241236650 / +91 - 998 729 5242 


Figure 48: Demographics, Philippines, Births (per 1,000 Population), 20082013 

Figure 49: Demographics, Philippines, Mortality (per 1,000 Population), 20082013 

Figure 50: Demographics, Philippines, Major Causes of Mortality (000), 2010 

Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 Live Births), 20082013 

Figure 52: Demographics, Philippines, Immunization Rate (%), 20082013 

Figure 53: Demographics, Philippines, Major Causes of Male Mortality (000), 2008 

Figure 54: Demographics, Philippines, Major Causes of Female Mortality (000), 2008 

Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 Live Births), 20082010 

Figure 56: Demographics, Philippines, Gender Ratio (M:F), 20082013 

Figure 57: Demographics, Philippines, Life Expectancy at Birth (Years), 20082013 

Figure 58: Demographics, Philippines, Life Expectancy at Birth (Years), 20142020 

Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 20082013 

Figure 60: Demographics, Philippines, Unemployment Rate (%), 20082013 

Figure 61: Demographics, Philippines, Major Diseases, Morbidity (000), 2010 

Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 Population), 2009 

Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 20082013 

Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 20082013 

Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 

Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 

Population), 20072009 

Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 Population), 

20082013 

Figure 68: Environmental Health, Philippines, CO2 Emissions (Million Tons), 20082013 

Figure 69: Environmental Health, Philippines, PM10 (gm/m), 20082013 

Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 20082013 

Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 20082013 

Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 20082013 

Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2011 

Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 20082013 

Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2013 

Related reports: 

Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014 

Skin Infections - Pipeline Review, H1 2014 

Restenosis - Pipeline Review, H1 2014 



Tel No- 91 2241236650 / +91 - 998 729 5242 


About JSB Market Research:- 

JSB market research is a leading player in the market of research report distribution. 

It is one-stop-shop for all information related to market research for any sector of the 

industry. Along with providing in-depth analysis though reports, JSB market research 

also provides regular updates of the market though newsletters. Our reports are a wellresearched 

work of market researchers with an extensive knowledge and a good level 

of market experience. 

To know more on “CountryFocus: Healthcare, Regulatory and Reimbursement 

Landscape Philippines” 

http://www.jsbmarketresearch.com/healthcare-medical/r-CountryFocus-Healthcare- 

Regulatory-and-Reimbursement-Landscape-Philippines-114974 



Tel No- 91 2241236650 / +91 - 998 729 5242

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?